In this cohort of Tanzanian children, the TNF−1031 CC genotype was associated with increased rates of malarial episodes, whereas the TNF−308 AA genotype was associated with decreased rates.
Malaria Journal 2015, 14:249 (20 June 2015)
PLoS ONE 5(11): e14090
The malaria vaccine candidate, RTS,S/AS01E, showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability.